Biotechnology invention studio that develops platform technologies and products for multigenic therapies and spins out independent companies to enable larger investments and scalable commercialization. Sells next-generation platform tools to the biopharma industry while concurrently developing in-house multigenic therapeutics, beginning with cardiac-focused programs.